Drawing for GOGLICO

USPTO serial 79195459

GOGLICO

Reviewed by CopyMark Law Group

Reg. 5293459Status 709
Filing date
Status date
Registration date
Sep 26, 2017
Examiner
SHANOSKI, JOANNA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GOGLICO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 S. Jackson Street, Suite 200Glendale, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Glucose for use as an additive to foods for medical purposes; nutritional supplements for medical purposes; cachets for pharmaceutical purposes; gelatin for medical purposes; medicinal healthcare preparations for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct the hypoglycemia; chemical preparations for medical purposes, namely to correct hypoglycemias or other diseases that imply the need of sugar or similar substances to correct imbalances; bracelets for medical purposes; empty capsules for pharmaceuticals; pharmaceutical compositions, namely preparations with glycose to allow correcting hypoglycemia in diabetics or hypotensives; medicated lozenges; Pharmaceutical preparations, namely, elixirs for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; anti-diabetic pharmaceuticals; autonomic drugs for medical purposes; glucose for medical purposes; anti-diabetic preparations; cardiovascular treatment preparations; glucose preparations for medical purposes; pharmaceutical preparations and substances for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for human use for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct the hypoglycemia; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations, namely, for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemia; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of disorders of the endocrine system; chemico-pharmaceutical preparations for the treatment of diabetes and hypotension or other diseases where it is vital to carry the sugar to correct hypoglycemiaSECTION 71 - CANCELLED—
010Wrist braces for medical use; applicators for medications sold empty, namely, applicators transported close to the body containing glycose in a capsule to allow the user to correct hypoglycemia; applicators for pharmaceutical preparations sold empty, namely, applicators transported close to the body containing glycose in a capsule to allow the user to correct hypoglycemia; medical braces for application to the human body, namely, around the arm, forearm or wristSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 5, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 5, 2025INPCINVALIDATION PROCESSED—
Dec 13, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 12, 2024C71TCANCELLED SECTION 71—
Sep 26, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 2, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 29, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 16, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 16, 2018FIMPFINAL DISPOSITION PROCESSED—
Dec 26, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 26, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 11, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 30, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 30, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 30, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 30, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
May 30, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 24, 2016RFNTREFUSAL PROCESSED BY IB—
Dec 2, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 2, 2016RFRRREFUSAL PROCESSED BY MPU—
Nov 12, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 11, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 11, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2016DOCKASSIGNED TO EXAMINER—
Nov 7, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 3, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance